Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015 (2015), Article ID 293564, 8 pages
http://dx.doi.org/10.1155/2015/293564
Research Article

The Power of Phase I Studies to Detect Clinical Relevant QTc Prolongation: A Resampling Simulation Study

1Statistik Georg Ferber GmbH, Cagliostrostrasse 14, 4125 Riehen, Switzerland
2Richmond Pharmacology Ltd., St George’s, University of London, Cranmer Terrace, London SW17 0RE, UK
3Cardiovascular and Cell Sciences Research Institute, St George’s, University of London, Cranmer Terrace, London SW17 0RE, UK

Received 20 March 2015; Revised 22 May 2015; Accepted 9 June 2015

Academic Editor: Giuseppe Biondi-Zoccai

Copyright © 2015 Georg Ferber et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. ICH, “E14 clinical evaluation of QT/QTc prolongation and proarrhythmic potential for non-antiarrhythmic drugs,” in Proceedings of the International Conference on Harmonisation: ICH Topic, 2005, http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E14/E14_Guideline.pdf.
  2. J. C. Bouvy, M. A. Koopmanschap, R. R. Shah, and H. Schellekens, “The cost-effectiveness of drug regulation: the example of thorough QT/QTc studies,” Clinical Pharmacology & Therapeutics, vol. 91, no. 2, pp. 281–288, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. J. A. Florian, C. W. Tornøe, R. Brundage, A. Parekh, and C. E. Garnett, “Population pharmacokinetic and concentration-QTc models for moxifloxacin: pooled analysis of 20 thorough QT studies,” Journal of Clinical Pharmacology, vol. 51, no. 8, pp. 1152–1162, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Täubel, A. H. Wong, A. Naseem, G. Ferber, and A. J. Camm, “Shortening of the QT interval after food can be used to demonstrate assay sensitivity in thorough QT studies,” The Journal of Clinical Pharmacology, vol. 52, no. 10, pp. 1558–1565, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. B. Darpo, C. Garnett, C. T. Benson et al., “CSRC White paper: can the thorough QT/QTc study be replaced by ‘early QT assessment’ in routine clinical pharmacology studies? Scientific update and a research proposal for a path forward,” American Heart Journal, vol. 168, pp. 262–272, 2014. View at Google Scholar
  6. B. Darpo and C. Garnett, “Early QT assessment—how can our confidence in the data be improved?” British Journal of Clinical Pharmacology, vol. 76, no. 5, pp. 642–648, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Rohatagi, T. J. Carrothers, J. Kuwabara-Wagg, and T. Khariton, “Is a thorough QTC study necessary? The role of modeling and simulation in evaluating the QTC prolongation potential of drugs,” Journal of Clinical Pharmacology, vol. 49, no. 11, pp. 1284–1296, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. R. R. Shah and J. Morganroth, “Early investigation of QTc liability: the role of multiple ascending dose (MAD) study,” Drug Safety, vol. 35, no. 9, pp. 695–709, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. B. Darpo, N. Sarapa, C. Garnett et al., “The IQ-CSRC prospective clinical phase 1 study: ‘Can early QT assessment using exposure response analysis replace the thorough QT study?’,” Annals of Noninvasive Electrocardiology, vol. 19, no. 1, pp. 70–81, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. C. E. Garnett, N. Beasley, V. A. Bhattaram et al., “Concentration-QT relationships play a key role in the evaluation of proarrhythmic risk during regulatory review,” The Journal of Clinical Pharmacology, vol. 48, no. 1, pp. 13–18, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. G. Ferber, M. Zhou, and B. Darpo, “Detection of QTc effects in small studies—implications for replacing the thorough QT study,” Annals of Noninvasive Electrocardiology, 2014. View at Publisher · View at Google Scholar
  12. J. Täubel, A. Naseem, D. Wang, R. Arezina, U. Lorch, and A. J. Camm, “Repeated supratherapeutic dosing of strontium ranelate over 15 days does not prolong QTc interval in healthy volunteers,” British Journal of Clinical Pharmacology, vol. 74, no. 2, pp. 296–303, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Täubel, A. Naseem, T. Harada et al., “Levofloxacin can be used effectively as a positive control in thorough QT/QTc studies in healthy volunteers,” British Journal of Clinical Pharmacology, vol. 69, no. 4, pp. 391–400, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Naseem, T. Harada, D. Wang et al., “Bupivacaine extended release liposome injection does not prolong QTc interval in a thorough QT/QTc study in healthy volunteers,” Journal of Clinical Pharmacology, vol. 52, no. 9, pp. 1441–1447, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Täubel, G. Ferber, U. Lorch, V. Batchvarov, I. Savelieva, and A. J. Camm, “Thorough QT study of the effect of oral moxifloxacin on QTc interval in the fed and fasted state in healthy Japanese and Caucasian subjects,” British Journal of Clinical Pharmacology, vol. 77, no. 1, pp. 170–179, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. L. S. Fridericia, “Die Systolendauer im Elektrokardiogramm bei normalen Menschen und bei Herzkranken,” Acta Medica Scandinavica, vol. 54, no. 1, pp. 17–50, 1921. View at Publisher · View at Google Scholar
  17. G. Ferber, D. Wang, and J. Täubel, “Concentration-effect modeling based on change from baseline to assess the prolonging effect of drugs on QTc together with an estimate of the circadian time course,” The Journal of Clinical Pharmacology, vol. 54, no. 12, pp. 1400–1406, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. R Core Team, “R: a language and environment for statistical computing,” R Foundation for Statistical Computing, Vienna, Austria, http://www.r-project.org/.
  19. J. Pinheiro, D. Bates, S. DebRoy, D. Sarkar, and R Core Team, “nlme: Linear and Nonlinear Mixed Effects Models. R package version 3.1-118,” http://CRAN.R-project.org/package=nlme.
  20. J. Täubel and G. Ferber, “The reproducibility of QTc changes after meal intake,” Journal of Electrocardiology, vol. 48, no. 2, pp. 274–275, 2015. View at Publisher · View at Google Scholar
  21. N. S. Nair, I. M. Brennan, T. J. Little et al., “Reproducibility of energy intake, gastric emptying, blood glucose, plasma insulin and cholecystokinin responses in healthy young males,” British Journal of Nutrition, vol. 101, no. 7, pp. 1094–1102, 2009. View at Publisher · View at Google Scholar · View at Scopus